Interferon-induced helicase C domain-containing protein 1 (IFIH1) (MDA5)

Interferon-induced helicase C domain-containing protein 1, commonly known as MDA5, is a cytosolic pattern recognition receptor that plays a critical role in the innate immune system by sensing long double-stranded RNA (dsRNA). Upon binding to dsRNA—often a byproduct of viral replication or a component of mRNA vaccine formulations—MDA5 undergoes a conformational change and oligomerizes, subsequently activating the MAVS signaling pathway (UniProt Q9BYX4). This cascade induces the expression of Type I interferons and other pro-inflammatory cytokines, which are essential for establishing an antiviral state and enhancing the adaptive immune response to vaccines (PubMed: 35013195). While MDA5 is vital for defense against viruses like picornaviruses and coronaviruses, its dysregulation is linked to autoimmune conditions such as Aicardi-Goutières syndrome and clinically amyopathic dermatomyositis (PubMed: 24509471). In the context of mRNA vaccines, MDA5 acts as a key sensor that contributes to the vaccine's adjuvant effect, though excessive activation is a consideration in vaccine-related inflammatory side effects (PubMed: 34432564).

Other names

Melanoma differentiation-associated protein 5MDA-5IFIH1CADM-140 autoantigenClinically amyopathic dermatomyositis autoantigen 140 kDaHelicardRIG-I-like receptor 2RLR-2

Activation of MDA5 by long double-stranded RNA (dsRNA) leads to its oligomerization and recruitment of the adapter protein MAVS (Mitochondrial antiviral-signaling protein). This triggers a signaling cascade involving IRF3, IRF7, and NF-kappaB, resulting in the transcriptional upregulation of Type I and III interferons and pro-inflammatory cytokines.